Targeting Interleukin-4 Receptor Alpha by Hybrid Peptide for Novel Biliary Tract Cancer Therapy

<table>Expression levels of IL-4R<i>α</i> in BTC cells. Cell lysates were prepared from six BTC cell lines. <i>β</i>-Actin was used as an internal control.</table>

International Journal of Hepatology

fig1

Figure 1

Figure 1: Targeting Interleukin-4 Receptor Alpha by Hybrid Peptide for Novel Biliary Tract Cancer Therapy 